A carregar...
Guanfacine Decreases Symptoms of Cannabis Withdrawal in Daily Cannabis Smokers
The α2a-adrenergic agonist, lofexidine, reduced cannabis withdrawal-related sleep disruption in the laboratory, but side effects (e.g., fatigue, hypotension) limit its utility as a treatment for cannabis use disorder (CUD). This study tested the potential efficacy and tolerability of a daily bedtime...
Na minha lista:
| Publicado no: | Addict Biol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6191371/ https://ncbi.nlm.nih.gov/pubmed/29659126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/adb.12621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|